FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marc Mousli

Research Profile

Anatomy

Chemicals & Drugs

Physiology

Histamine Release

Living Beings

Concepts & Ideas

Molecular Sequence Data

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Mayada Achour; Mahmoud Alhosin; Sirano Dhe-Paganon; Ali Hamiche; Abdulkhaleg Ibrahim; Marc Mousli; Christian MULLER; Jean Peluso; Valérie B Schini-Kerth; Christian BRONNER
Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1.
Mahmoud Alhosin; Tanveer Sharif; Marc Mousli; Nelly Etienne-Selloum; Guy Fuhrmann; Valérie B Schini-Kerth; Christian BRONNER
Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.
Aziza Akaddar; Cécile Doderer-Lang; Melissa R Marzahn; François Delalande; Marc Mousli; Karen Helle; Alain Van Dorsselaer; Dominique Aunis; Ben M Dunn; Marie-Hélène Metz-Boutigue; Ermanno Candolfi
Catestatin, an endogenous chromogranin A-derived peptide, inhibits in vitro growth of Plasmodium falciparum.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marc Mousli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mayada Achour; Mahmoud Alhosin; Sirano Dhe-Paganon; Ali Hamiche; Abdulkhaleg Ibrahim; Marc Mousli; Christian MULLER; Jean Peluso; Valérie B Schini-Kerth; Christian BRONNER
Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1.
Biochemical and biophysical research communications 2013;430(1):208-12.
2011: Mahmoud Alhosin; Tanveer Sharif; Marc Mousli; Nelly Etienne-Selloum; Guy Fuhrmann; Valérie B Schini-Kerth; Christian BRONNER
Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.
Journal of experimental & clinical cancer research : CR 2011;30():41.
2010: Aziza Akaddar; Cécile Doderer-Lang; Melissa R Marzahn; François Delalande; Marc Mousli; Karen Helle; Alain Van Dorsselaer; Dominique Aunis; Ben M Dunn; Marie-Hélène Metz-Boutigue; Ermanno Candolfi
Catestatin, an endogenous chromogranin A-derived peptide, inhibits in vitro growth of Plasmodium falciparum.
Cellular and molecular life sciences : CMLS 2010;67(6):1005-15.
2010: Ibtissem Lahmar; Marie Guinard; Arnaud Sauer; Luc Marcellin; Tamer Abdelrahman; Michel Roux; Marc Mousli; Adnan Moussa; Hamouda Babba; Alexander W Pfaff; Ermanno Candolfi
Murine neonatal infection provides an efficient model for congenital ocular toxoplasmosis.
Experimental parasitology 2010;124(2):190-6.
2009: Mayada Achour; Guy Fuhrmann; Mahmoud Alhosin; Philippe Rondé; Thierry Chataigneau; Marc Mousli; Valérie B Schini-Kerth; Christian BRONNER
UHRF1 recruits the histone acetyltransferase Tip60 and controls its expression and activity.
Biochemical and biophysical research communications 2009;390(3):523-8.
2009: Motoko Unoki; Julie Brunet; Marc Mousli
Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis.
Biochemical pharmacology 2009;78(10):1279-88.
2009: Ibtissem Lahmar; Ahmed Abou-Bacar; Tamer Abdelrahman; Marie Guinard; Hamouda Babba; Salim Ben Yahia; Moncef Kairallah; Claude Speeg-Schatz; Tristan Bourcier; Arnaud Sauer; Odile Villard; Alexander W Pfaff; Marc Mousli; Justus G Garweg; Ermanno Candolfi
Cytokine profiles in toxoplasmic and viral uveitis.
The Journal of infectious diseases 2009;199(8):1239-49.
2009: A Senegas; Odile Villard; Agnès Neuville; Luc Marcellin; Alexander W Pfaff; T Steinmetz; Marc Mousli; Jean-Paul Klein; Ermanno Candolfi
Toxoplasma gondii-induced foetal resorption in mice involves interferon-gamma-induced apoptosis and spiral artery dilation at the maternofoetal interface.
International journal for parasitology 2009;39(4):481-7.
2008: Julie Brunet; Alexander W Pfaff; Ahmed Abidi; Motoko Unoki; Yusuke Nakamura; Marie Guinard; Jean-Paul Klein; Ermanno Candolfi; Marc Mousli
Toxoplasma gondii exploits UHRF1 and induces host cell cycle arrest at G2 to enable its proliferation.
Cellular microbiology 2008;10(4):908-20.
2008: Motoko Unoki; Christian BRONNER; Marc Mousli
A concern regarding the current confusion with the human homolog of mouse Np95, ICBP90/UHRF1.
Radiation research 2008;169(2):240-4.
2008: Alexander W Pfaff; Marc Mousli; Alexandre Sénégas; Luc Marcellin; Osamu Takikawa; Jean-Paul Klein; Ermanno Candolfi
Impact of foetus and mother on IFN-gamma-induced indoleamine 2,3-dioxygenase and inducible nitric oxide synthase expression in murine placenta following Toxoplasma gondii infection.
International journal for parasitology 2008;38(2):249-58.
2007: Alexander W Pfaff; Ahmed Abou-Bacar; Valérie Letscher-Bru; Odile Villard; A Senegas; Marc Mousli; Ermanno Candolfi
Cellular and molecular physiopathology of congenital toxoplasmosis: the dual role of IFN-gamma.
Parasitology 2007;134(Pt 13):1895-902.
2005: Alexander W Pfaff; Odile Villard; Jean-Paul Klein; Marc Mousli; Ermanno Candolfi
Regulation of Toxoplasma gondii multiplication in BeWo trophoblast cells: cross-regulation of nitric oxide production and polyamine biosynthesis.
International journal for parasitology 2005;35(14):1569-76.
2005: Michaël Jeanblanc; Marc Mousli; Raphaël Hopfner; Kawtar Bathami; Nadine Martinet; Abdul-Qader Abbady; Jean-Claude Siffert; Eric Mathieu; Christian MULLER; Christian BRONNER
The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle.
Oncogene 2005;24(49):7337-45.
2005: Alexander W Pfaff; Sophie Georges; Ahmed Abou-Bacar; Valérie Letscher-Bru; Jean-Paul Klein; Marc Mousli; Ermanno Candolfi
Toxoplasma gondii regulates ICAM-1 mediated monocyte adhesion to trophoblasts.
Immunology and cell biology 2005;83(5):483-9.
2005: Abdul-Qader Abbady; Christian BRONNER; Kawtar Bathami; Christian MULLER; Michaël Jeanblanc; Eric Mathieu; Jean-Paul Klein; Ermanno Candolfi; Marc Mousli
TCR pathway involves ICBP90 gene down-regulation via E2F binding sites.
Biochemical pharmacology 2005;70(4):570-9.
2005: Rohan Rajapakse; Marc Mousli; Alexander W Pfaff; Béatrice Uring-Lambert; Luc Marcellin; Christian BRONNER; Michaël Jeanblanc; Odile Villard; Valérie Letscher-Bru; Jean-Paul Klein; Ermanno Candolfi
1,25-Dihydroxyvitamin D3 induces splenocyte apoptosis and enhances BALB/c mice sensitivity to toxoplasmosis.
The Journal of steroid biochemistry and molecular biology 2005;96(2):179-85.
2004: Christian BRONNER; Marie-Aline Trotzier; Odile Filhol; Claude Cochet; Cécile Rochette-Egly; Marie Schöller-Guinard; Jean-Paul Klein; Marc Mousli
The antiapoptotic protein ICBP90 is a target for protein kinase 2.
Annals of the New York Academy of Sciences 2004;1030():355-60.
2004: Marie-Aline Trotzier; Christian BRONNER; Kawtar Bathami; Eric Mathieu; Abdul-Qader Abbady; Michaël Jeanblanc; Christian MULLER; Cécile Rochette-Egly; Marc Mousli
Phosphorylation of ICBP90 by protein kinase A enhances topoisomerase IIalpha expression.
Biochemical and biophysical research communications 2004;319(2):590-5.
2004: Yoshimi Arima; Toru Hirota; Christian BRONNER; Marc Mousli; Toshiyoshi Fujiwara; Shin-ichiro Niwa; Hiroyuki Ishikawa; Hideyuki Saya
Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition.
Genes to cells : devoted to molecular & cellular mechanisms 2004;9(2):131-42.
2003: Abdul-Qader Abbady; Christian BRONNER; Marie-Aline Trotzier; Raphaël Hopfner; Kawtar Bathami; Christian MULLER; Michaël Jeanblanc; Marc Mousli
ICBP90 expression is downregulated in apoptosis-induced Jurkat cells.
Annals of the New York Academy of Sciences 2003;1010():300-3.
2003: Marc Mousli; Raphaël Hopfner; Abdul-Qader Abbady; didier monte; Michaël Jeanblanc; Pierre Oudet; B Louis; Christian BRONNER
ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells.
British journal of cancer 2003;89(1):120-7.
2002: Raphaël Hopfner; Marc Mousli; Pierre Oudet; Christian BRONNER
Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression.
Anticancer research 2002;22(6A):3165-70.
2002: Christian BRONNER; Raphaël Hopfner; Marc Mousli
Transcriptional regulation of the human topoisomerase IIalpha gene.
Anticancer research 2002;22(2A):605-12.
2001: Raphaël Hopfner; Marc Mousli; Jean-Marie Garnier; Richard Redon; Stanislas du Manoir; Bruno Chatton; N Ghyselinck; Pierre Oudet; Christian BRONNER
Genomic structure and chromosomal mapping of the gene coding for ICBP90, a protein involved in the regulation of the topoisomerase IIalpha gene expression.
Gene 2001;266(1-2):15-23.
2000: Laurent Brino; Alexandre Urzhumtsev; Marc Mousli; Christian BRONNER; Andre Mitschler; Pierre Oudet; Dino Moras
Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center.
The Journal of biological chemistry 2000;275(13):9468-75.
2000: Raphaël Hopfner; Marc Mousli; Jean-Marc Jeltsch; A Voulgaris; Yves Lutz; C Marin; Jean-Pierre Bellocq; Pierre Oudet; Christian BRONNER
ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression.
Cancer research 2000;60(1):121-8.
1999: Laurent Brino; Christian BRONNER; Pierre Oudet; Marc Mousli
Isoleucine 10 is essential for DNA gyrase B function in Escherichia coli.
Biochimie 1999;81(10):973-80.
1998: Ahmed Chahdi; Marc Mousli; Yves Landry
Substance P-related inhibitors of mast cell exocytosis act on G-proteins or on the cell surface.
European journal of pharmacology 1998;341(2-3):329-35.
1998: Laurent Brino; Marc Mousli; Pierre Oudet; E Weiss
Expression in Escherichia coli of Y5 mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
Plasmid 1998;39(1):21-34.
1997: Laurent Brino; Marc Mousli; Pierre Oudet; E Weiss
Expression in Escherichia coli of Y5-mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
Plasmid 1997;38(3):188-201.
1996: J G Van Gelderen; Laurent Daeffler; D Scherrer; Marc Mousli; Yves Landry; Jean-Pierre Gies
M2-muscarinic receptors: how does ligand binding affinity relate to intrinsic activity?
Journal of receptor and signal transduction research 1996;16(1-2):135-48.
1995: B Emadi-Khiav; Marc Mousli; Yves Landry
Role of G-proteins in peptidergic activation of both human and rat cutaneous mast cells.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 1995;44 Suppl 1():S26-7.
1995: Marc Mousli; A Trifilieff; J T Pelton; Jean-Pierre Gies; Yves Landry
Structural requirements for neuropeptide Y in mast cell and G protein activation.
European journal of pharmacology 1995;289(1):125-33.
1995: B Emadi-Khiav; Marc Mousli; C Bronner; Yves Landry
Human and rat cutaneous mast cells: involvement of a G protein in the response to peptidergic stimuli.
European journal of pharmacology 1995;272(1):97-102.
1994: E Lach; A Trifilieff; Marc Mousli; Yves Landry; Jean-Pierre Gies
Bradykinin-induced contraction of guinea pig lung in vitro.
Naunyn-Schmiedeberg's archives of pharmacology 1994;350(2):201-8.
1994: Marc Mousli; Yves Landry
Role of positive charges of neuropeptide Y fragments in mast cell activation.
Agents and actions 1994;41 Spec No():C41-2.
1994: A Trifilieff; E Lach; Marc Mousli; E B Haddad; Yves Landry; Jean-Pierre Gies
Co-solubilization of bradykinin B2 receptors and angiotensin-converting enzyme from guinea pig lung membranes.
Biochimica et biophysica acta 1994;1191(1):109-16.
1994: Marc Mousli; T E Hugli; Yves Landry; C Bronner
Peptidergic pathway in human skin and rat peritoneal mast cell activation.
Immunopharmacology 1994;27(1):1-11.
1993: Jean-Pierre Gies; Y Landry; Marc Mousli
Receptor-independent activation of mast cells by bradykinin and related peptides.
Trends in neurosciences 1993;16(12):498-9.
1993: Jean-Luc Bueb; Marc Mousli; Yves Landry; D Regoli
Structure-activity studies of bradykinin analogues on rat mast cell histamine release.
Peptides 1993;14(4):685-9.
1993: T Fischer; C Bronner; Yves Landry; Marc Mousli
The mechanism of inhibition of alkylamines on the mast-cell peptidergic pathway.
Biochimica et biophysica acta 1993;1176(3):305-12.
1992: Marc Mousli; T E Hugli; Yves Landry; C Bronner
A mechanism of action for anaphylatoxin C3a stimulation of mast cells.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(8):2456-61.
1992: Jean-Luc Bueb; A Da Silva; Marc Mousli; Yves Landry
Natural polyamines stimulate G-proteins.
The Biochemical journal 1992;282 ( Pt 2)():545-50.
1992: D Hillaire-Buys; Marc Mousli; Y Landry; J Bockaert; J A Fehrentsz; J Carrette; Bruno Rouot
Insulin releasing effects of mastoparan and amphiphilic substance P receptor antagonists on RINm5F insulinoma cells.
Molecular and cellular biochemistry 1992;109(2):133-8.
1991: Marc Mousli; C Bronner; Jean-Luc Bueb; Yves Landry
Evidence for the interaction of mast cell-degranulating peptide with pertussis toxin-sensitive G proteins in mast cells.
European journal of pharmacology 1991;207(3):249-55.
1991: Jean-Luc Bueb; Marc Mousli; Yves Landry
Molecular basis for cellular effects of naturally occurring polyamines.
Agents and actions 1991;33(1-2):84-7.
1991: Marc Mousli; Jean-Luc Bueb; Bruno Rouot; Yves Landry; C Bronner
G-proteins as targets for non-immunological histamine releasers.
Agents and actions 1991;33(1-2):81-3.
1990: Jean-Luc Bueb; Marc Mousli; C Bronner; Bruno Rouot; Yves Landry
Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells.
Molecular pharmacology 1990;38(6):816-22.
1990: Marc Mousli; Jean-Luc Bueb; C Bronner; Bruno Rouot; Yves Landry
G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides.
Trends in pharmacological sciences 1990;11(9):358-62.
1990: Marc Mousli; C Bronner; J Bockaert; Bruno Rouot; Yves Landry
Interaction of substance P, compound 48/80 and mastoparan with the alpha-subunit C-terminus of G protein.
Immunology letters 1990;25(4):355-7.
1990: Jean-Luc Bueb; Marc Mousli; Yves Landry; C Bronner
A pertussis toxin-sensitive G protein is required to induce histamine release from rat peritoneal mast cells by bradykinin.
Agents and actions 1990;30(1-2):98-101.
1990: Marc Mousli; Jean-Pierre Gies; C Bertrand; F Pelen; C Bronner; Yves Landry
The sensitivity to Zn2+ discriminates between typical and atypical mast cells.
Agents and actions 1990;30(1-2):102-5.
1990: Yves Landry; J G Bloch; Marc Mousli; Jean-Luc Bueb; C Bronner
[Neuropeptides and inflammation: presumed mechanisms in neurogenic inflammation].
Pathologie-biologie 1990;38(1):53-6.
1990: Marc Mousli; C Bronner; Yves Landry; J Bockaert; Bruno Rouot
Direct activation of GTP-binding regulatory proteins (G-proteins) by substance P and compound 48/80.
FEBS letters 1990;259(2):260-2.
1989: C Bronner; Marc Mousli; N Eleno; Yves Landry
Resting plasma membrane potential of rat peritoneal mast cells is set predominantly by the sodium pump.
FEBS letters 1989;255(2):401-4.
1989: Marc Mousli; C Bronner; Jean-Luc Bueb; Eric Tschirhart; Jean-Pierre Gies; Yves Landry
Activation of rat peritoneal mast cells by substance P and mastoparan.
The Journal of pharmacology and experimental therapeutics 1989;250(1):329-35.
1989: E Popin; C Bertrand; Marc Mousli; Gabrielle Pauli; Y Landry
[Bronchial peptidergic control and concepts of neurogenic inflammation].
Revue de pneumologie clinique 1989;45(4):141-3.